Stock CANQF CANAQUEST MEDICAL CORP.
Add to a list
To use this feature you must be a member
Log inSign up

All News CanaQuest Medical Corp.

Equities

CANQF

CA1372201097

Market Closed - OTC Markets
Other stock markets
 07:12:32 24/05/2024 pm IST 		5-day change 1st Jan Change
0.09 USD +0.11% Intraday chart for CanaQuest Medical Corp. -10.00% -62.50%
2023 NHL Alumni Association Partners with CanaQuest and NEEKA Health to Conduct Studies for Anxiety and Quality of Life in Former NHL Players CI
2023 CanaQuest Medical Corp. cancelled the transaction announced on October 26, 2022 CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
NHL Alumni Association Partners with CanaQuest and NEEKA Health to Conduct Studies for Anxiety and Quality of Life in Former NHL Players
CI
CanaQuest Medical Corp. cancelled the transaction announced on October 26, 2022
CI
CANAQUEST Announces Award of European Cannabinoid Patent
AQ
CanaQuest Medical Corp. Announces Award of European Cannabinoid Patent
CI
CanaQuest Awarded Best Global Medical Cannabinoid Development Company 2023 by UK-based Global Health and Pharma for their 8th Annual Healthcare and Pharmaceutical Program
AQ
CanaQuest Achieves Statistically Significant Reduction of Seizures for Epilepsy Compared to Standard CBD
CI
CanaQuest Medical Corp. announced a financing transaction
CI
CanaQuest Medical Corp. Launches Mentanine (R) (Cannabidiol + IP Formula) in the US
CI
CanaQuest Medical : Interim Consolidated Consolidated Financial Statements (unaudited) - June 30, 2022
PU
CanaQuest Medical : Attorney Letter
PU
CanaQuest Medical : Financial Statements (unaudited) - March 31, 2022
PU
CanaQuest Medical Corp. Appoints Rob Rinderman as New Director of Communications
CI
Canaquest Signs Medicinal Cannabis Education Partnership with the Canadian Cannabis Dispute Resolution Centre
CI
CANAQUEST MEDICAL CORP Announces New Production and Distribution Agreement with PurCann Pharma and SiliCycle Inc
CI
CANAQUEST MEDICAL CORP SECURES APPROVAL FOR LISTING ON THE OCMX™, AN ONLINE INVESTOR AND FINANCIAL CONNECTION PORTAL
GL
UPDATE: CANAQUEST MEDICAL CORP FILES PROVISIONAL PATENT FOR MENTANINE® - OMEGA-3 & PURE CANNABIDIOL (“CBD”) FORMULATION BOOSTING MENTAL HEALTH EFFICACY WHILE MINIMIZING CBD DOSAGE
GL
CANAQUEST MEDICAL CORP FILES PROVISIONAL PATENT FOR MENTANINE® - OMEGA-3 & PURE CANNABIDIOL (“CBD”) FORMULATION BOOSTING MENTAL HEALTH EFFICACY WHILE MINIMIZING CBD DOSAGE
GL
CanaQuest Medical Corp. Files A Provisional Cannabidiol/Omega-3 Patent, Trade Named Mentanine®
CI
Canaquest Medical Corp Awaits Health Canada Approval for Sales and Export of Mentabinol®
GL
CanaQuest Medical Corp Awaits Health Canada Approval for Sales and Export of Mentabinol®
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CANQF Stock
  4. News CanaQuest Medical Corp.